Vanguard Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,767,268
Closed -$12.8M 4198
2019
Q1
$12.8M Buy
2,767,268
+655,261
+31% +$3.03M ﹤0.01% 2696
2018
Q4
$7.39M Sell
2,112,007
-549,317
-21% -$1.92M ﹤0.01% 2914
2018
Q3
$26.8M Buy
2,661,324
+119,776
+5% +$1.21M ﹤0.01% 2445
2018
Q2
$18.4M Buy
2,541,548
+151,546
+6% +$1.1M ﹤0.01% 2600
2018
Q1
$14.4M Sell
2,390,002
-147,084
-6% -$888K ﹤0.01% 2631
2017
Q4
$24.4M Buy
2,537,086
+244,979
+11% +$2.36M ﹤0.01% 2413
2017
Q3
$20.4M Sell
2,292,107
-41,147
-2% -$365K ﹤0.01% 2484
2017
Q2
$29.5M Sell
2,333,254
-17,853
-0.8% -$226K ﹤0.01% 2282
2017
Q1
$24.7M Sell
2,351,107
-29,785
-1% -$313K ﹤0.01% 2360
2016
Q4
$21.9M Sell
2,380,892
-1,812
-0.1% -$16.7K ﹤0.01% 2385
2016
Q3
$28.1M Sell
2,382,704
-2,077
-0.1% -$24.5K ﹤0.01% 2208
2016
Q2
$30.9M Sell
2,384,781
-107,214
-4% -$1.39M ﹤0.01% 2131
2016
Q1
$39.8M Buy
2,491,995
+216,373
+10% +$3.46M ﹤0.01% 1969
2015
Q4
$65.2M Buy
2,275,622
+414,581
+22% +$11.9M ﹤0.01% 1757
2015
Q3
$53M Buy
1,861,041
+61,149
+3% +$1.74M ﹤0.01% 1837
2015
Q2
$64.7M Buy
1,799,892
+76,662
+4% +$2.75M ﹤0.01% 1796
2015
Q1
$50.1M Buy
1,723,230
+469,136
+37% +$13.6M ﹤0.01% 1911
2014
Q4
$26.4M Sell
1,254,094
-38,810
-3% -$818K ﹤0.01% 2139
2014
Q3
$25.1M Buy
1,292,904
+306,126
+31% +$5.94M ﹤0.01% 2109
2014
Q2
$15.4M Buy
986,778
+27,904
+3% +$436K ﹤0.01% 2315
2014
Q1
$19.9M Buy
958,874
+574,430
+149% +$11.9M ﹤0.01% 2181
2013
Q4
$4.96M Buy
384,444
+113,586
+42% +$1.47M ﹤0.01% 2804
2013
Q3
$3.16M Buy
270,858
+20,331
+8% +$237K ﹤0.01% 2950
2013
Q2
$1.16M Buy
+250,527
New +$1.16M ﹤0.01% 3266